CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 20 enrolled
Drug / intervention
Testosterone +1 moredrug
Likely dose
Not stated in record
Key inclusion· 1
  • Healthy college-aged female participants aged 18-24 years
Key exclusion· 8
  • Tree nut allergy
  • Pregnant, possibly pregnant, or breastfeeding
  • Taking supplements that may influence testosterone level
  • Taking any kind of steroid that may increase testosterone level

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05781685
NCT05781685Early Ph 1Completed

The Influence of Testosterone on Experimental Pain Perception and Social Psychological Functioning

University of New Mexico·interventional·Posted Mar 23, 2023·Updated Aug 5, 2024

In Brief

A Early Phase 1 clinical trial evaluating Testosterone and Placebo Syrup for Acute Pain. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This trial examined how the administration of exogenous testosterone would influence pain tolerance and other endogenous steroids (i.e. estradiol and progesterone).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Pain
CountriesUnited States

Timeline

Early Ph 1CompletedFinished
201820192020202120222023202420252026
First PostedMar 23, 2023
Enrollment StartOct 1, 2017
Primary CompletionJul 17, 2018
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 3.3 years ago

Interventions

Testosteronedrug

Sublingual testosterone was administered to participants. Participants would self-administer the testosterone to themselves.

Placebo Syrupother

Oil-based sublingual product.